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Abstract Neutrophils are professional phagocytic
cells that play a crucial role in innate immunity.
Through an assortment of antifungal effector mecha-
nisms, neutrophils are essential in controlling the early
stages of fungal infection. These mechanisms range
from the production of reactive oxygen intermediates
and release of antimicrobial enzymes to the formation
of complex extracellular traps that aid in the elimina-
tion of the fungus. Their importance in antifungal
immunity is supported by the extreme susceptibility to
infection of patients with primary (e.g., chronic
granulomatous disease) or acquired (e.g., undergoing
immunosuppressive therapy) neutrophil deficiency.
More recently, common genetic variants affecting
neutrophil antifungal capacity have also been dis-
closed as major risk factors for aspergillosis in
conditions of generalized immune deficiency. The
present review revisits the role of neutrophils in the
host response against Aspergillus and highlights the
consequences of their deficiency in susceptibility to
aspergillosis.
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Introduction
Neutrophils are professional phagocytes of the innate
immune system that are essential to control bacterial
and fungal infection. Clinical evidence has long
suggested a prominent role for these cells in the
defense against invasive aspergillosis (IA). Patients
suffering from chronic granulomatous disease (CGD)
have a dramatically increased risk of IA, and after the
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introduction of bone-marrow transplantation, it was
soon realized that the duration of neutropenia is one of
the key determinants of risk for IA in the respective
patients. Over the last decades, experimental studies
have revealed a prominent role of neutrophils in
engulfing and killing Aspergillus fumigatus through a
variety of effector mechanisms. In addition, recent
advances in genetics of fungal infection have provided
further insights into effector functions with important
impact on the antifungal activity of neutrophils. This
review highlights the role of neutrophils in the host
immune response to A. fumigatus and addresses the
consequences of their qualitative or quantitative
insufficiency to susceptibility to aspergillosis.
Fungal Sensing and Immune Activation
of Neutrophils
Humans routinely inhale small fungal spores from A.
fumigatus—mostly without adverse consequences,
except perhaps for allergic sensitization. The first line
of resistance against invasion by the fungus is
conferred by the physical barriers of the respiratory
tract. In the event that fungal spores escape the ciliated
epithelium and reach lung alveoli, they will then be
challenged by cells of the innate immune system,
including resident alveolar macrophages and dendritic
cells. Consequently, everyday inhalation of Aspergil-
lus spores will normally not result in inflammation and
recruitment of inflammatory cells.
Neutrophils have long been recognized as an
essential innate cell defense against IA, as the duration
and extent of neutropenia as well as qualitative defects
in neutrophil function (e.g., patients with CGD) are the
most pervasive risk factors for the development of IA
[1]. These findings are recapitulated in animal models
in which antibody-mediated depletion of neutrophils
[2] or absence of functional nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase, which is
required for generating reactive oxygen intermediates,
[3] leads to uncontrolled fungal growth in the lung and
mortality from aspergillosis.
Unlike macrophages, neutrophils are only rarely
found in the lungs of naı¨ve mice. However, this
situation changes dramatically within a few hours after
infection with A. fumigatus, as neutrophils are rapidly
recruited to the site of infection [4]. This has been
demonstrated to occur mostly due to the release of a
subset of the CXC family of chemokine ligands by
alveolar macrophages [5]. Moreover, the proinflam-
matory cytokine interleukin (IL)-1b, which is pro-
duced upon infection, directly induces chemokine
release by lung epithelial cells [6]. The production of
chemokines in the lung also correlated with the
accumulation of monocytes/macrophages and expres-
sion of T helper (Th) 1-associated cytokines at the site
of infection, suggesting an association between neu-
trophil recruitment and chemokine production by
other cell types [5]. This notion is further supported
by the finding that inflammatory monocytes, by
conditioning the lung inflammatory milieu, modulate
the conidiocidal activity of neutrophils [7].
Neutrophils express a vast repertoire of pattern
recognition receptors (PRRs) that sense pathogen-
associated molecular patterns (PAMPs) on the surface
of conidia and drive the secretion of proinflammatory
cytokines and chemokines that arbitrate immune
responses and antifungal activity [8]. Fungal sensing
is further assisted by the action of collectins, ficolins,
pentraxins, and complement components that act as
opsonins and facilitate the interaction of neutrophils
with fungi. Similar to other phagocytes, neutrophils
recognize and internalize fungal spores upon recogni-
tion by PRRs such as toll-like receptor (TLR)2, TLR4,
or dectin-1 [9]. Of interest, mutations in caspase-
associated recruitment domain 9 (CARD9), a signal-
ing molecule downstream dectin-1, have been associ-
ated with impaired neutrophil killing and
susceptibility to severe Candida infection [10].
Whether CARD9 deficiency can also predispose to
aspergillosis remains to be elucidated. Despite the fact
that signaling PRRs are present on neutrophils [11],
evidence demonstrating cytokine and chemokine
release by neutrophils is scarce. A few exceptions
include the in vitro release of chemokine (C-X-C
motif) ligands 1, 2, and 3 and chemokine (C–C motif)
ligands 2, 3, and 4 by artificially stimulated neutro-
phils [12] and the upregulation of IL-8 production
assessed after TLR2- and TLR4-dependent stimula-
tion of neutrophils with A. fumigatus antigens [13].
One of the other important aspects regarding
neutrophil activation has been provided recently. In
a model of A. fumigatus-induced keratitis, neutrophils
were found to express the transcription factor retinoic
acid-related orphan receptor ct (RORct) and induced
the expression of IL-17A, IL-17 receptor C (IL-
17RC), and dectin-2 [14]. This revealed the existence
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of a novel neutrophil population with autocrine IL-17
activity that likely contributes to the inflammatory
response against the fungus. In contrast, A. fumigatus
is endowed with the ability to suppress neutrophil-
dependent inflammatory responses. The hydrophobin
layer of fungal spores, by masking dectin-1- and
dectin-2-dependent recognition, restrains neutrophil
infiltration and cytokine production [15, 16]. In
addition, galactosaminogalactan (GAG), an immuno-
suppressive polysaccharide of the fungal cell wall
produced by glucose epimerases [17], inhibits neutro-
phil infiltration and promotes fungal development
even in immunocompetent mice [18]. Moreover, GAG
functions as the dominant adhesin of A. fumigatus,
mediating adherence and suppressing host inflamma-
tory responses, in part through masking cell wall
b-glucans from recognition by dectin-1 [19]. The
immunomodulatory properties of GAG have also been
attributed to its ability to induce IL-1 receptor
antagonist (IL-1Ra) [20]. Ultimately, these findings
suggest that targeting IL-1Ra in IA might be a
therapeutic possibility to be exploited in the future.
Antifungal Effector Mechanisms of Neutrophils
Phagocytosis
Like macrophages, neutrophil granulocytes are ‘‘pro-
fessional’’ phagocytic cells and one main antimicro-
bial function of this cell type is the killing of microbes
after internalization (Fig. 1). The phagocytic activity
of neutrophils relies on the opsonization of fungal
spores. Among the opsonins identified to bind A.
fumigatus, the long pentraxin 3 (PTX3) has been
demonstrated to play a nonredundant role in antifungal
host defense [21]. More importantly, PTX3 is stored in
the granules of neutrophils in a ready-made form and
undergoes release in response to fungal recognition
and inflammatory signals [22]. This enables the
formation of complexes on the conidial surface, thus
enhancing recognition and phagocytosis through
mechanisms that depend on Fcc receptor, CD11b,
and complement activation [23]. This pivotal role of
PTX3 in response to A. fumigatus has also been
recently confirmed in humans. A functional donor
haplotype in the human PTX3 gene has been demon-
strated to increase the risk of IA among recipients of
allogeneic hematopoietic stem cell transplantation
[24]. This susceptibility phenotype was associated
with a qualitative defect in the ability of newly
reconstituted neutrophils to ingest and kill the fungus
and not directly with the neutrophil counts.
Accumulating evidence suggests that neutrophils
also communicate strongly with other components of
the immune system. It has long been known that the
activation of the complement system is closely linked
to neutrophil activation. Fungal surfaces are triggers of
complement activation, whereas fungi have evolved
several mechanisms to escape complement activity,
suggesting that a main function of complement
activation may be the stimulation of neutrophils [25,
26]. Neutrophils have also been shown to interact with
natural killer (NK) cells, which are activated by A.
fumigatus. Aspergillus-induced activation of NK cells
can lead to secretion of cytokines such as tumor
necrosis factor (TNF)-a, interferon (IFN)-c, and
granulocyte macrophage colony-stimulating factor
(GM-CSF) which in turn directly stimulate neutrophil
activation [27–29]. On the other hand, it is noteworthy
that GAG is able to induce neutrophil apoptosis
through a NK cell-dependent mechanism [30], sug-
gesting that NK cells may play a role during neutro-
penia or autoimmune diseases. In a recent study, a
receptor on the surface of NK cells recognizing fungi
has been identified for the first time [31]. These data
suggest that there is likely to be more to neutrophils
function than just killing of the invading pathogen. For
this reason, elucidating the role of neutrophils in IA is
crucial for an in-depth understanding of the immun-
obiology of this disease.
Reactive Oxygen Species (ROS)
Each phagocytic event results in the formation of a
phagosome into which ROS and hydrolytic enzymes
are released after its fusion with lysosomes. Indeed,
patients with CGD owing to an inborn deficiency of
NADPH oxidase are highly susceptible to IA [32].
Neutrophils of these patients show markedly deficient
NADPH oxidase activity and are unable to adequately
produce superoxide anions and other reactive oxygen
intermediates. These findings have been confirmed in
animal models of CGD, either gp91phox- or p47phox-
deficient [3, 33]. The fact that gp91phox-deficient
alveolar macrophages, but not neutrophils, efficiently
controlled the growth of A. fumigatus conidia [33]
suggests that neutrophils rely on ROS production to
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eliminate the fungus. However, it is also true that CGD
patients are exposed to Aspergillus conidia every day,
yet considerable numbers of them survive years
without infection, thus suggesting that neutrophils
from these patients may also use ROS-independent
mechanisms to counter the fungus. Consequently,
ROS may be exclusively relevant in activating vacu-
olar enzymes [34, 35], suggesting that these enzymes
may be responsible for the direct killing effect. One
such example is the myeloperoxidase enzyme that
critically relies on the presence of an oxidative
environment for its proper function. Indeed, when
released in the context of the oxidative burst, it
generates the potent antimicrobial hydrochlorous acid
from hydrogen peroxide and chloride anion [36].
Therefore, it is not surprising that myeloperoxidase-
deficient mice are also susceptible to IA, though
relatively less than NADPH oxidase-deficient animals
[37]. Another emerging finding regards the possibility
of neutrophil cluster formation and that formation of
these oxidative-active aggregates may represent a
novel antimicrobial mechanism preventing the germi-
nation of A. fumigatus conidia [33].
Granule Enzymes
Besides their phagocytic activity, neutrophils possess a
very unique ability to counter invading pathogens.
Following recognition, these cells are able to secrete
antimicrobial compounds stored in their granules
during a process called degranulation. This provides
the cell with an effective mechanism to injure patho-
gens that are impossible to phagocytose, such as the
large hyphae of A. fumigatus [38]. Indeed, neutrophils
were initially thought to exclusively promote hyphal
damage. However, recent studies showed that neutro-
phils are also able to eliminate spores from the infected
lungs of macrophage-depleted mice [39].
There is also in vitro evidence to suggest that
neutrophils can mediate antifungal activities via nonox-
idative mechanisms. For example, knockout mice
lacking neutrophil proteases cathepsin G and elastase
that do not require ROS for their proper function were
found to be susceptible to A. fumigatus infection [40].
This has been nonetheless challenged by the finding that
neutrophil proteases may have a redundant role in
antifungal host defense [41]. In addition, neutrophils
release lactoferrin as part of their degranulation when
interacting with A. fumigatus conidia [42]. The
antifungal function of lactoferrin appears to rely on the
sequestration of iron and inhibition of conidial growth
[43]. In this regard, cell-free supernatants of degranu-
lated ROS-deficient neutrophils (which had abundant
lactoferrin) were able to suppress conidial growth.
Further adding to the complexity of this mechanism,
human neutrophils have been found to synthesize
lipocalin-1, which by sequestering fungal siderophores
restricts fungal growth [44]. This points to the existence
of specific host iron-chelating and fungal iron-acquisi-
tion mediators regulating fungal growth. Finally, PTX3
is also stored in neutrophil granules, and besides its role
as opsonin, PTX3 localizes to neutrophil structures
known as neutrophil extracellular traps (NETs) (dis-
cussed below) upon activation [22].
NETosis
NETosis is a recently discovered neutrophil-depen-
dent defensive system. During this process, dying
neutrophils actively secrete their nuclear DNA and
throw it on extracellular pathogens resulting in NET
formation [45]. The process of NET formation
depends on the induction of a ROS-mediated signaling
cascade in neutrophils that ends up in the disintegra-
tion of the nuclear envelope and granular membranes
[46]. Indeed, NADPH oxidase has been found to be
required for generation of NETs in vivo, suggesting
that the modulation of NETosis by NADPH oxidase
enhances antifungal host defense and promotes reso-
lution of inflammation upon infection clearance [47].
This is further supported by the finding that restoration
of NADPH oxidase activity in CGD patients has been
shown to reestablish NETosis and restore fungal
defense against A. nidulans [48]. Pathogens coming in
contact with the NETs are immobilized, thereby
limiting the spread of infection. In addition, NETs
also facilitate pathogen elimination, as they contain a
number of antibacterial proteins, including PTX3 [22],
defensins, the cathelicidin LL37 [49], histones [45], or
calprotectin [50]. Although NET formation in
response to A. fumigatus has been demonstrated
in vitro [22] and in vivo in a lung infection model
[4, 9], a direct effect of these structures in fungal
killing has not yet been demonstrated. Of note, the
RodA hydrophobin of A. fumigatus, previously shown
to inhibit immune cell activation [15], has also been
shown to inhibit NET formation, thus revealing the
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first molecularly defined fungal escape strategy from
NETs.
Future Perspectives
Current evidence demonstrates the importance of
neutrophils in controlling fungal clearance in Asper-
gillus infections. Insufficient neutrophil counts (e.g.,
in patients undergoing hematopoietic stem cell trans-
plantation) and specific qualitative defects owing to
primary immunodeficiency (e.g., in CGD patients)
have historically been considered the most important
risk factors for severe Aspergillus infections. How-
ever, for most individuals at risk, propensity to
aspergillosis will have a polygenic source. A genetic
variant by itself has a negligible effect, and only in
combination with other remarkable predisposing
variants (e.g., profound immunosuppression), sizeable
phenotypic effects will arise. Indeed, our own studies
have recently identified common genetic variants
influencing neutrophil function that predispose to
fungal infection in particular conditions of immune
dysfunction such as those observed in patients under-
going hematopoietic stem cell transplantation [24].
Genetic deficiency of signal transducer and activator
of transcription 3 (STAT3) has also been found to
increase risk of IA in patients with hyper-IgE
syndrome [51]. However, in this case, it does not
seem to affect neutrophil function and is instead likely
related to impaired lung epithelial homeostasis and
defense. The dissection of the genetic bases underly-
ing susceptibility to infectious diseases inspires a very
active, yet complex, field of research [52]. As the
awareness of the individual genetic makeup may hold
the key to expose unsuspected risk factors for these
diseases, the current understanding of the immuno-
logical network involved in the immune response to
Aspergillus needs to be addressed also from a genetic
point of view. In addition, as shown for PTX3
deficiency [24], targeting neutrophil function (e.g.,
exogenous administration of lacking or deficient
factors) may prove an interesting approach to be
validated in the future.
Fig. 1 Major antifungal effector mechanisms of neutrophils.
Neutrophils can eliminate Aspergillus by multiple means, both
intra- and extracellular. When neutrophils come into contact with
the fungus, they phagocytose and kill it using NADPH oxidase-
dependent mechanisms or antibacterial proteins. The antibacterial
proteins are released from the neutrophil granules either into
phagosomes or into the extracellular milieu. Highly activated
neutrophils can also eliminate extracellular fungi by releasing
NETs. These structures immobilize fungi, preventing their
spreading but also facilitating their subsequent phagocytosis
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Given the efforts carried out aiming at the detection
of accurate prognostic markers and currently ongoing
genome-wide studies [53], it is expected that novel
genetic variants affecting neutrophil function may be
identified in the future. These may provide important
implications regarding patient outcome and health-
care costs in a near future by allowing the discrim-
ination of patients that require enhanced surveillance
for fungal disease and/or alternative antifungal
therapies.
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